Extension Study for the Port Delivery System With Ranibizumab (Portal)

Clinical trial NCT03683251 · RECRUITING

Trial details

NCT number: NCT03683251
Sponsor: Hoffmann-La Roche
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neovascular Age-Related Macular Degeneration

Start date: 2018-09-20
Primary completion: 2029-12-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.